Levocetirizine is an antihistamine medication used to treat allergy symptoms. It belongs to the class of second generation h1 receptor blockers. The drug works by blocking histamine receptors in the body, preventing the release of inflammatory signals. By occupying these receptors it reduces itching, sneezing, watery eyes and runny nose. Levocetirizine selectively inhibits peripheral h1 receptors with minimal penetration of the blood brain barrier. The inhibition leads to decreased histamine mediated vasodilation and mucus secretion in the nasal passages. This targeted action provides relief from allergic reactions without causing significant sedation.

Levocetirizine is a second generation antihistamine used to relieve allergy symptoms. It works by blocking histamine h1 receptors in tissues that mediate allergic responses. By preventing histamine from binding to these receptors, the drug reduces itching, sneezing, and runny nose. The molecule is a metabolite of cetirizine that enhances its selectivity for peripheral receptors. Its pharmacokinetic profile leads to prolonged action and low central nervous system penetration. Overall, Levocetirizine modulates immune signaling to provide symptom relief without causing significant sedation.

Levocetirizine may cause drowsiness in a small number of users. Headache is a commonly reported side effect that usually resolves on its own. Some people experience dry mouth or mild throat irritation. Fatigue or a feeling of tiredness can occur after dosing. In rare cases, mild skin rash or itching may develop. Most side effects are transient and do not require medical intervention.

Levocetirizine may cause mild drowsiness in some individuals. Headache and dry mouth are among the frequently reported adverse effects. Less common side effects include abdominal pain and fatigue. Rarely, users may experience dizziness or mild skin rash. These reactions are generally transient and resolve without intervention. The medication's safety profile indicates that most users tolerate it well.